![]() |
市場調查報告書
商品編碼
1831984
血紅素檢測市場報告,按產品類型(試劑和耗材、設備)、技術(色譜法、免疫測定法等)、最終用戶(實驗室、醫院、研究中心)和地區分類,2025 年至 2033 年Hemoglobin Testing Market Report by Product Type (Reagents and Consumables, Equipment), Technology (Chromatography, Immunoassay, and Others), End-User (Laboratories, Hospitals, Research Centers), and Region 2025-2033 |
2024年,全球血紅素檢測市場規模達25.5億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到41.2億美元,2025-2033年期間的複合年成長率(CAGR)為5.22%。糖尿病和貧血等慢性病的發生率上升正在刺激市場發展。
即時檢驗需求不斷成長
向即時檢測 (POCT) 的轉變是血紅蛋白監測市場的重大發展,因為它可以在傳統實驗室之外提供快速且方便的檢測。攜帶式分析儀可快速提供結果,從而改善患者護理和決策。 2024 年 6 月,堀場製作所推出了新型緊湊型血液學分析儀,包括 Yumizen H550E(自動進樣器)、H500E CT(閉管式)和 Yumizen H500E OT(開管式)。這些分析儀可在 60 秒內提供全血 CBC/DIFF 和 ESR 結果的聯合檢測。
人工智慧(AI)在診斷中的應用日益廣泛
血紅蛋白檢測市場正在探索人工智慧(AI),該技術正迅速應用於血紅蛋白檢測,以提高準確性和效率。人工智慧系統可以快速評估巨量資料集,最大限度地減少人為錯誤,提高診斷準確性。這是血紅蛋白檢測市場的促進因素之一。 2024年8月,印度理工學院(IIT)卡拉格普爾分校與薩蒂亞賽醫院(Sathya Sai Hospital)合作進行人工智慧貧血篩檢。此次合作旨在開發創新解決方案,以應對弱勢群體面臨的貧血挑戰。
提高對貧血的認知與篩檢
貧血是一種與低血紅素水平相關的疾病,其早期識別正變得越來越重要。世界各國政府和衛生組織正在啟動篩檢項目,以識別易感人群(例如孕婦和兒童)的貧血。 2024年2月,印度兒科學會(IAP)發起了一項全國性活動,以提高人們對貧血和其他重要兒童健康問題的認知。
The global hemoglobin testing market size reached USD 2.55 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.12 Billion by 2033, exhibiting a growth rate (CAGR) of 5.22% during 2025-2033. An increase in chronic conditions, including diabetes and anemia, is stimulating the market.
Rising Demand for Point-of-Care Testing
The shift to point-of-care testing (POCT) is a significant development in the hemoglobin monitoring market as it provides quick, convenient testing outside of traditional labs. Portable analyzers deliver quick results, which improves patient care and decision-making. In June 2024, Horiba launched new compact hematology analyzers, namely, Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube). They offer combined testing for CBC/DIFF with ESR results from whole blood in 60 seconds.
Growing Use of Artificial Intelligence (AI) in Diagnostics
The hemoglobin testing market overview is exploring AI, which is rapidly being used in hemoglobin testing to improve accuracy and efficiency. AI-powered systems can swiftly evaluate big datasets, minimizing human error and improving diagnosis accuracy. This is one of the hemoglobin testing market drivers. In August 2024, IIT Kharagpur collaborated with Sathya Sai Hospital for AI-powered anemia screening. This joint effort focuses on developing innovative solutions to address the challenges of anemia in underprivileged populations.
Increasing Awareness and Screening for Anemia
Early identification of anemia, a disorder associated with low hemoglobin levels, is becoming increasingly important. Governments and health organizations around the world are launching screening programs to identify anemia in susceptible populations, such as pregnant women and children. In February 2024, the Indian Academy of Pediatrics (IAP) launched a nationwide campaign to raise awareness about anemia and other crucial child health issues.
As per the hemoglobin testing market share analysis, reagents and consumables, such as test strips and other disposable materials, have a strong presence in the market due to their widespread use in diagnostic procedures. The equipment segment, which includes analyzers and point-of-care devices, is experiencing considerable growth due to technical developments and rising demand for portable testing solutions.
Chromatography is frequently utilized for precise and thorough hemoglobin variant analysis, especially in laboratory settings where precision is crucial. Meanwhile, immunoassay technology is gaining popularity because of its speed and cost-effectiveness, making it ideal for point-of-care testing and routine hemoglobin monitoring in a variety of healthcare settings. These segments are contributing to shaping hemoglobin testing market dynamics.
According to the hemoglobin testing industry statistics, laboratories hold a considerable proportion due to their ability to do high-volume testing and extensive analysis. Hospitals play an important role in hemoglobin testing for patient diagnosis and monitoring. Moreover, research institutions contribute to market growth by developing new testing methods and diagnostic technologies.
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
As per the hemoglobin testing market outlook, advanced healthcare systems and extensive diagnostic tool usage are pushing the market in North America. Europe benefits from strong government healthcare assistance and heightened awareness of early detection. Asia Pacific is experiencing rapid growth due to its large population, rising healthcare awareness, and improving medical infrastructure. In Latin America, the market is growing as healthcare systems improve and focus on malnutrition-related illnesses. The Middle East and Africa region is evolving, with more access to healthcare, increased investment in diagnostics, and initiatives to tackle regional health challenges such as anemia.